STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Files An 8-K Other Events

ME Staff 8-k
-
0

STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Files An 8-K Other Events
Item 8.01.Other Events.

On December 20, 2017, Strata Skin Sciences, Inc., a Delaware corporation (the "Company"), announced that Ms. LuAnn Via had been unanimously appointed as its Chairperson of its Board of Directors. Ms. Via is a current Board member and Chair of the Company's Compensation Committee. The Board made the appointment after Jeffrey O'Donnell, Sr. informed the Board that, because of the growing needs of his other commitments, he could no longer devote the time and energy as required by the position of Chairman. Mr. O'Donnell will remain a member of the Company's Board of Directors.

Mr. O'Donnell's consulting agreement with the Company will terminate at the end of its current term on December 31, 2017.

On December 20, 2017, the Company issued a press release announcing the appointment of Ms. Via as Chairperson.A copy of the press release is furnished herewith as Exhibit 99.1.

Item 9.01.Financial Statements and Exhibits.

The following press release is furnished as an exhibit to this Current Report on Form 8-K to Item 2.02 and shall not be deemed to be "filed":

Exhibit Number

Description

99.1

Press Release by the Company, dated December 20, 2017.

Exhibit Index


STRATA Skin Sciences, Inc. Exhibit
EX-99.1 2 ex_99-1.htm STRATA PRESS RELEASE DATED 12-20-17 REGARDING BOARD CHAIRPERSON   EXHIBIT 99.1       STRATA Skin Sciences Announces Appointment of LuAnn Via as Chairperson of the Board Horsham,…
To view the full exhibit click here

About STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN)

STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company’s technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.